Subscribe to RSS
DOI: 10.1055/s-0042-1755232
Neuromuscular diseases and social distance resulting from the COVID-19 pandemic
Doenças neuromusculares e o distanciamento social decorrente da pandemia COVID-19Abstract
Background Coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2), generically called COVID-2019, classified as a pandemic by the World Health Organization, has made health practices around the world face unique challenges. Since then, physical distancing and measures such as confinement have been adopted by different governments to control human-to-human transmission. This distance affected the treatment of individuals with progressive diseases such as neuromuscular diseases (NMDs).
Objective To identify how patients with NMDs performed the therapeutic routine during social distancing and confinement resulting from the COVID-19 pandemic.
Methods Application of a questionnaire prepared in the Google forms application, whose link for access and participation was sent by email or WhatssApp for family members and/or individuals with DNMs to respond. The questionnaire consisted of multiple-choice questions, divided into the following sections: personal data, treatments performed before and during the pandemic, activities performed during confinement, and characterization of motor function in activities of daily living comprising the period between September and October 2020.
Results We observed a significant reduction in medical appointments for patients with NMDs. On the other hand, the results showed that most patients underwent motor and/or respiratory physiotherapy in person or by telemonitoring. The study participants reported spending more time playing indoors, and all pointed out motor changes during social distancing.
Conclusion There were changes in the therapeutic routine of patients with NMDs during the period of social distancing due to COVID-19.
Resumo
Antecedentes A síndrome respiratória aguda grave por coronavírus 2 (SARS-CoV-2), genericamente chamada de COVID-2019, classificada como pandemia pela Organização Mundial da Saúde, tem feito as práticas de saúde em todo o mundo enfrentar desafios únicos. Desde então, o distanciamento físico e medidas como o confinamento foram adotadas por diferentes governos para controlar a transmissão inter-humana. Este distanciamento afetou o tratamento de indivíduos com doenças progressivas, como no caso das doenças neuromusculares (DNMs).
Objetivo Identificar como os pacientes com DNMs realizaram a rotina terapêutica durante o distanciamento social e confinamento decorrentes da pandemia de COVID-19.
Métodos Aplicação de um questionário elaborado no aplicativo Google forms, cujo link para acesso e participação foi enviado por e-mail ou WhatssApp para familiares e/ou indivíduos com DNMs responderem. O questionário consistiu em questões de múltipla escolha, dividido nas seguintes sessões: dados pessoais, tratamentos realizados antes e durante a pandemia, atividades realizadas durante o confinamento e caracterização das funções motoras nas atividades de vida diária, referente ao período de setembro a outubro de 2020.
Resultados Observamos uma redução significativa nas consultas médicas dos pacientes com DNMs. Por outro lado, os resultados demonstraram que a maior parte dos pacientes realizou fisioterapia motora e/ou respiratória de modo presencial ou por telemonitoramento. Os participantes do estudo relataram gastar mais tempo com atividades dentro de casa, além de todos terem apontado mudanças motoras durante o distanciamento social.
Conclusão Houve mudanças na rotina terapêutica de pacientes com DNM durante o período de distanciamento social da COVID-19.
Keywords
COVID-19 - Neuromuscular Diseases - Physical Therapy Modalities - Locomotion - Drug TherapyPalavras-chave
COVID-19 - Doenças Neuromusculares - Modalidades de Fisioterapia - Locomoção - Tratamento FarmacológicoAuthors' Contributions
All authors participated in the design, execution, and analysis of the paper, and all authors have reviewed and approved the present manuscript.
Publication History
Received: 15 October 2021
Accepted: 13 December 2021
Article published online:
29 September 2022
© 2022. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Yang ML, Finkel RS. Overview of paediatric neuromuscular disorders and related pulmonary issues: diagnostic and therapeutic considerations. Paediatr Respir Rev 2010; 11 (01) 9-17
- 2 WMS – Covid-19 e doentes com doenças neuromusculares: Posição e recomendações da “World Muscle Society” (WMS) Versão 2 – atualização em 06/04/2020 – Brazil. https://www.worldmusclesociety.org/files/COVID19/2020-04-02/2020-04-02-WMS-Covid-19-advice-Portuguese (Brazilian)
- 3 Solé G, Salort-Campana E, Pereon Y. et al; FILNEMUS COVID-19 study group. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Rev Neurol (Paris) 2020; 176 (06) 507-515
- 4 Brasil - Ministério da saúde - https://antigo.saude.gov.br/saude-de-a-z/doencas-raras
- 5 Veerapandiyan A, Wagner KR, Apkon S. et al. The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic. Muscle Nerve 2020; 62 (01) 41-45
- 6 Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology 2020; 94 (22) 959-969
- 7 Beggiora H. Google Forms: o que é e como usar o app de formulários online. Tech Tudo Consultado Junho 2020. https://www.techtudo.com.br/dicas-e-tutoriais/2020/04/como-usar-o-google-forms-saiba-criar-um-formulario-online.ghtml
- 8 Bersano A, Pantoni L. On being a neurologist in Italy at the time of the COVID-19 outbreak. Neurology 2020; 94 (21) 905-906
- 9 Anziska Y, Inan S. Exercise in neuromuscular disease. Semin Neurol 2014; 34 (05) 542-556
- 10 Schwamm LH, Chumbler N, Brown E. et al; American Heart Association Advocacy Coordinating Committee. Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association. Circulation 2017; 135 (07) e24-e44
- 11 Siciliano G, Schirinzi E, Simoncini C, Ricci G. Exercise therapy in muscle diseases: open issues and future perspectives. Acta Myol 2019; 38 (04) 233-238
- 12 Di Stefano V, Battaglia G, Giustino V. et al. Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine. J Neurol 2021; 268 (01) 20-26
- 13 World Health Organization Q&A on coronaviruses (COVID-19). WHO; Geneva: 2020
- 14 Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun 2020; 87: 34-39
- 15 Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health 2020; 25 (03) 278-280
- 16 Narici M, De Vito G, Franchi M. et al. Impact of sedentarism due to the COVID-19 home confinement on neuromuscular, cardiovascular and metabolic health: physiological and pathophysiological implications and recommendations for physical and nutritional countermeasures. Eur J Sport Sci 2021; 21 (04) 614-635
- 17 Butterfield RJ, Johnson NE. Neuromuscular Disease. J Pediatr Rehabil Med 2016; 9 (01) 1-2